These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25622943)

  • 1. Risk of Clostridium difficile infection in intensive care unit patients with sepsis exposed to metronidazole.
    Sabbah MA; Schorr C; Czosnowski QA; Hunter K; Torjman MC; Fraimow HS; Zanotti S; Tsigrelis C
    Infect Dis (Lond); 2015 Apr; 47(4):197-202. PubMed ID: 25622943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection.
    Shaughnessy MK; Micielli RL; DePestel DD; Arndt J; Strachan CL; Welch KB; Chenoweth CE
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):201-6. PubMed ID: 21460503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological study of Clostridium difficile infection in critical patients admitted to the Intensive Care Unit.
    Alvarez-Lerma F; Palomar M; Villasboa A; Amador J; Almirall J; Posada MP; Catalan M; Pascual C;
    Med Intensiva; 2014 Dec; 38(9):558-66. PubMed ID: 24503331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).
    Manthey CF; Dranova D; Christner M; Drolz A; Kluge S; Lohse AW; Fuhrmann V
    Crit Care; 2019 Dec; 23(1):399. PubMed ID: 31815650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.
    van Beurden YH; Dekkers OM; Bomers MK; Kaiser AM; van Houdt R; Knetsch CW; Girbes AR; Mulder CJ; Vandenbroucke-Grauls CM
    PLoS One; 2016; 11(8):e0160778. PubMed ID: 27533048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit.
    Dodek PM; Norena M; Ayas NT; Romney M; Wong H
    J Crit Care; 2013 Aug; 28(4):335-40. PubMed ID: 23337482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile in the ICU: study of the incidence, recurrence, clinical characteristics and complications in a university hospital.
    Salva S; Duran N; Rodriguez V; Nieto L; Serra J; Rello J;
    Med Intensiva; 2014 Apr; 38(3):140-5. PubMed ID: 23769945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
    Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
    BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of ICU patients with Clostridium difficile infection.
    Zahar JR; Schwebel C; Adrie C; Garrouste-Orgeas M; Français A; Vesin A; Nguile-Makao M; Tabah A; Laupland K; Le-Monnier A; Timsit JF;
    Crit Care; 2012 Nov; 16(6):R215. PubMed ID: 23127327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clostridium difficile in visceral surgery].
    Herzog T; Deleites C; Belyaev O; Chromik AM; Uhl W
    Chirurg; 2015 Aug; 86(8):781-6. PubMed ID: 25432576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
    Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
    Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.